SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-112237
Filing Date
2014-03-24
Accepted
2014-03-24 15:42:07
Documents
3
Period of Report
2014-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d692814d8k.htm 8-K 15152
2 EX-99.1 d692814dex991.htm EX-99.1 47843
3 GRAPHIC g692814ex99_1logo.jpg GRAPHIC 14358
  Complete submission text file 0001193125-14-112237.txt   84021
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 14713156
SIC: 2834 Pharmaceutical Preparations